Related Experiment Videos
Hepatitis B virus: the importance of age at infection
Insights
Vaccinating infants and young children against hepatitis B virus (HBV) is more impactful than vaccinating adults. Lower vaccine doses for more children can efficiently control endemic HBV.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Age at infection significantly influences Hepatitis B Virus (HBV) outcomes.
- Infant and preschooler HBV infections carry higher risks of chronic carriage, cirrhosis, and hepatocellular carcinoma.
- Adult HBV infections are more severe acutely but less likely to become chronic.
Purpose of the Study:
- To evaluate the impact of age at infection on Hepatitis B Virus (HBV) outcomes.
- To inform efficient HBV vaccination strategies in endemic regions.
- To optimize resource allocation for HBV control programs.
Main Methods:
- Analysis of existing studies on age-specific HBV infection outcomes.
- Comparative assessment of vaccination strategies based on age groups and dosage.
- Modeling the impact of different vaccination approaches on chronic HBV carriage rates.
Main Results:
- Infections in infants and young children lead to higher rates of chronic HBV carriage.
- Vaccinating children offers greater public health impact than vaccinating adults in endemic areas.
- Lower vaccine doses administered to a larger pediatric population may be more cost-effective for controlling chronic HBV.
Conclusions:
- Targeting infants and preschool children for HBV vaccination is crucial for reducing long-term sequelae like cirrhosis and cancer.
- Flexible vaccination strategies, including lower doses for broader coverage in children, can enhance HBV control in endemic settings.
- Prioritizing pediatric vaccination maximizes the impact of limited resources for HBV prevention.
Abstract:
Recent studies have demonstrated the importance of age at infection with hepatitis B virus (HBV). Age affects whether the infection is self-limited or results in the chronic carrier state, the severity of the acute infection, and the incidence of various sequelae of the chronic carrier state. In particular, although the acute infection is more severe in adults, infections in infants and preschool children carry much greater risks of chronic carriage which increases the risk of primary hepatocellular carcinoma and cirrhosis later in life. This has two important implications for areas where HBV is endemic. First, more impact can be gained by vaccinating infants and preschool children than by vaccinating healthy adults. Second, if funds are limited, greater impact will be gained by immunising a larger number of children with low doses of vaccine so that they are protected during the early years of life when the risk of chronic carriage is highest, rather than using the standard dose in a smaller number of children even though protection may be longer lasting with standard doses. These two considerations provide the basis for an efficient strategy for control in communities or countries where HBV is endemic or hyperendemic.